Stay updated with breaking news from Polypid Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PolyPid Ltd. (NASDAQ:PYPD – Get Rating) was down 1.2% during trading on Tuesday . The company traded as low as $0.40 and last traded at $0.41. Approximately 17,516 shares changed hands during trading, a decline of 95% from the average daily volume of 325,541 shares. The stock had previously closed at $0.41. PolyPid Stock Down […]
Operator: Greetings, and welcome to the PolyPid Fourth Quarter and Full Year 2022 Conference Call. . As a reminder, this call is recorded.
Raymond James Financial Services Advisors Inc. trimmed its position in shares of PolyPid Ltd. (NASDAQ:PYPD – Get Rating) by 36.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,814 shares of the company’s stock after selling 19,447 shares during the […]
Bioforum and Medidata have been working together for nearly a decade, with approximately 30 joint projects to date – half of which are ongoing....
Centralized Procedure Allows for Submission of a Single Marketing Application to the European Medicines Agency that, if Approved, Would Allow D-PLEX100 to be Marketed in All EU Member States ... | September 28, 2022